Back to all issues
Issue #40
April 21, 2026

5 year AI breast risk enters NCCN at 1.7%

PLUS: FDA rejects bid to ease radiology AI review

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.